Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

February 13, 2023

Study Completion Date

February 13, 2023

Conditions
Minimal Invasive Cardiac SurgeryMitral Valve SurgeryAortic Valve ReplacementMinimal Invasive Direct Coronary Artery Bypass
Interventions
DRUG

Levobupivacaine

"The Investigational Medical Product (IMP) is levobupivacaine 0,25%, 2,5 mg/ml, solution for injection. The dosage scheme is as following:1.25 mg/kg levobupivacaine 0,25%, with a maximum of 100 mg, As the standard anaesthetic management already contains levobupivacaine, a maximum dosage of 100 mg (40 ml) levobupivacaine will be administered during the SAPB.~The IMP is given via ultrasound-guided infiltration, in plane, midaxillary, 4-5th rib, between the latissimus dorsi and serratus anterior muscle, at the end of surgery."

Trial Locations (1)

9000

AZ Maria Middelares, Ghent

All Listed Sponsors
lead

Algemeen Ziekenhuis Maria Middelares

OTHER

NCT05107453 - Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery | Biotech Hunter | Biotech Hunter